Back to News
Weight Loss Meds Prescribing
Posted or Updated on 29 May 2025
Your GP practice will not be able to prescribe the weightless medication Mounjaro and Wegovy
Wegovy is the brand name for semaglutide, a drug which has been licensed and approved by the National Institute for Health and Care Excellence (NICE) for the management of obesity.
Monjuro is the brand name for tirzepatide, a drug which has been licensed and approved by the National Institute for Health and Care Excellence (NICE) for managing overweight and obesity.
Work is now being carried out with specialists across Kent and Medway to allow appropriate referrals to take place.
Read more about this on the Kent and Medway ICB website